Skip to Main Content

Author Details

John L Black
Mayo Clinic
1985
82
28
PMIDPaper TitleJournal TitlePublished Year
37373874Determination of the Duplicated <i>CYP2D6</i> Allele Using Real-Time PCR Signal: An Alternative Approach.J Pers Med2023
34671112Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.Pharmacogenomics J2022
35331649Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.Genet Med2022
32623598Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.Cardiovasc Drugs Ther2021
34747639Pharmacogenomics testing in patients with liver transplant and potential impact on prospective management.Pharmacogenomics2021
31378813Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).Int J Epidemiol2020
32214840Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics.Pharmgenomics Pers Med2020
32546429Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type.Hum Immunol2020
30745309Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in <i>CYP2C9</i> and <i>CYP2C19</i>.Drug Metab Dispos2019
30211780Associations of catechol-O-methyltransferase (rs4680) single nucleotide polymorphisms with opioid use and dose among adults with chronic pain.Pain2019
31041874Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.Mol Pain2019
27657685Multidisciplinary model to implement pharmacogenomics at the point of care.Genet Med2017
28243137Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.Pharmgenomics Pers Med2017
28213806Clinical UGT1A1 Genetic Analysis in Pediatric Patients: Experience of a Reference Laboratory.Mol Diagn Ther2017
28854070First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.J Clin Oncol2017
28769582<i>CYP2D6</i> phenotypes are associated with adverse outcomes related to opioid medications.Pharmgenomics Pers Med2017
27779246Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?Pharmacogenomics J2017
26947514Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.J Mol Diagn2016
26479518Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.Clin Pharmacol Ther2016
27289413Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine.Mayo Clin Proc2016
27371869Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients.J Mol Diagn2016
25714002Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen.Pharmacogenet Genomics2015
26434960Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes.Mayo Clin Proc2015
25671637Relationship of genetic variation in the serotonin transporter gene (SLC6A4) and congenital and acquired cardiovascular diseases.Genet Test Mol Biomarkers2015
24388019Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.Mayo Clin Proc2014
25141895Analysis of compound heterozygous CYP2C19 genotypes to determine cis and trans configurations.Pharmacogenomics2014
25109294Alternative method of allelic discrimination.Biotechniques2014
23895108Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain.BMC Med Genet2013
21741706Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients.Leuk Res2012
22652301Testing a diathesis-stress model: potential genetic risk factors for development of distress in context of acute leukemia diagnosis and transplant.Psychosomatics2012
22676198CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene.Pharmacogenomics2012
22004686Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.Drug Metab Dispos2012
21192344CYP2C19 variation and citalopram response.Pharmacogenet Genomics2011
22832606Simultaneous genotyping of multiple polymorphisms in human serotonin transporter gene and detection of novel allelic variants.Transl Psychiatry2011
22134958Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients.Depress Anxiety2011
21961651SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.Pharmacogenomics2011
20002020Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremens.Addict Biol2010
20439629Coprescription of tamoxifen and medications that inhibit CYP2D6.J Clin Oncol2010
18618621SLC6A4 variation and citalopram response.Am J Med Genet B Neuropsychiatr Genet2009
19741566CYP2D6: novel genomic structures and alleles.Pharmacogenet Genomics2009
19175764Sequence variations of the human MPDZ gene and association with alcoholism in subjects with European ancestry.Alcohol Clin Exp Res2009
19192461Serotonin transporter gene status and electroconvulsive therapy outcomes: a retrospective analysis of 83 patients.J Clin Psychiatry2009
18291691Narcolepsy: immunological aspects.Sleep Med Rev2008
17269892The impact of CYP allelic variation on antidepressant metabolism: a review.Expert Opin Drug Metab Toxicol2007
18079506Assessing attitudes about genetic testing as a component of continuing medical education.Acad Psychiatry2007
17803873Cytochrome P450 2D6 genotype variation and venlafaxine dosage.Mayo Clin Proc2007
16869367Obsessive compulsive disorder treatment in patients with Down syndrome: a case series.Downs Syndr Res Pract2006
16801827Patterns of psychotropic medication use among patients with severe depression referred for electroconvulsive therapy: data from the Consortium for Research on Electroconvulsive Therapy.J ECT2006
16043129Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.Biol Psychiatry2005
16401544Narcolepsy: a review of evidence for autoimmune diathesis.Int Rev Psychiatry2005
  • 1 - 50 of 82

Recommended Authors

Alexandra Popescu
Flinders Medical Centre
Career Start Year 2007
Number of shared co-authors 0
Jens R Wendland
Takeda Pharmaceuticals USA
Career Start Year 2000
Number of shared co-authors 0
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Career Start Year 1998
Number of shared co-authors 13
Norman Delanty
FutureNeuro SFI Research Centre, The Royal College of Surgeons in Ireland
Career Start Year 1992
Number of shared co-authors 2
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 2
Marcella Rietschel
Central Institute of Mental Health, University of Mannheim
Career Start Year 1990
Number of shared co-authors 6
Albert H C Wong
Campbell Family Mental Health Research Institute
Career Start Year 1990
Number of shared co-authors 0
Russell A Wilke
University of South Dakota Sanford School of Medicine
Career Start Year 1989
Number of shared co-authors 11
Markus M N??then
Institute of Human Genetics, University Hospital Bonn
Career Start Year 1989
Number of shared co-authors 10
Joachim Hallmayer
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Benjamin D Greenberg
Warren Alpert School of Medicine, Brown University, Butler Hospital
Career Start Year 1984
Number of shared co-authors 1
Vidar M Steen
University of Oslo, Oslo University Hospital
Career Start Year 1984
Number of shared co-authors 1
David A Collier
Institute of Psychiatry, King's College London
Career Start Year 1984
Number of shared co-authors 1
Peter R Schofield
University of New South Wales
Career Start Year 1984
Number of shared co-authors 3
James L Kennedy
Institute of Medical Sciences, University of Toronto
Career Start Year 1983
Number of shared co-authors 5
John R Kelsoe
University of California
Career Start Year 1982
Number of shared co-authors 4
Martin Schalling
Karolinska Institutet.
Career Start Year 1982
Number of shared co-authors 3
Robert H Lipsky
George Mason University
Career Start Year 1980
Number of shared co-authors 0
Douglas F Levinson
Stanford University School of Medicine
Career Start Year 1979
Number of shared co-authors 4
Laura J Fochtmann
Stony Brook University
Career Start Year 1979
Number of shared co-authors 0
Bruce M Cohen
Harvard Medical School
Career Start Year 1979
Number of shared co-authors 0
Giovanni Severino
University of Cagliari.
Career Start Year 1979
Number of shared co-authors 2
Wade H Berrettini
University of Pennsylvania
Career Start Year 1977
Number of shared co-authors 3
Jay Raymond DePaulo
Johns Hopkins University School of Medicine
Career Start Year 1977
Number of shared co-authors 3
David Goldman
Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism.
Career Start Year 1976
Number of shared co-authors 5
Maria Del Zompo
University of Cagliari.
Career Start Year 1976
Number of shared co-authors 4
Wolfgang Maier
University Hospital Bonn
Career Start Year 1972
Number of shared co-authors 6
Elliot S Gershon
University of Chicago
Career Start Year 1968
Number of shared co-authors 4
Wolfgang Sad??e
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 13
John I Nurnberger
Stark Neurosciences Research Institute, Indiana University School of Medicine
Career Start Year 1952
Number of shared co-authors 5

Collaborators

Richard M Weinshilboum
Mayo Clinic
Co-authored papers 12
Suzette J Bielinski
Mayo Clinic
Co-authored papers 12
Pedro J Caraballo
Mayo Clinic
Co-authored papers 8
Carolyn R Rohrer Vitek
Center for Individualized Medicine, College of Medicine, Mayo Clinic
Co-authored papers 7
Jennifer M Skierka
Mayo Clinic
Co-authored papers 7
Janet E Olson
Mayo Clinic
Co-authored papers 7
Liewei Wang
Mayo Clinic
Co-authored papers 6
Joanna M Biernacka
Mayo Clinic
Co-authored papers 6
Matthew P Goetz
Mayo Clinic
Co-authored papers 6
Linnea M Baudhuin
Mayo Clinic
Co-authored papers 5
V??ronique L Roger
National Heart Lung and Blood Institute
Co-authored papers 5
Nicholas B Larson
Mayo Clinic
Co-authored papers 5
Paul Y Takahashi
Mayo Clinic
Co-authored papers 5
Matthew A Hathcock
Mayo Clinic
Co-authored papers 4
Robert R Freimuth
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 4
Vera J Suman
Mayo Clinic
Co-authored papers 4
James N Ingle
Mayo Clinic
Co-authored papers 4
Eric D Wieben
Mayo Clinic Rochester
Co-authored papers 4
Eric W Klee
Mayo Clinic College of Medicine and Science
Co-authored papers 4
Gianrico Farrugia
Mayo Clinic Gastroenterology and Hepatology, Mayo Clinic
Co-authored papers 3
Jennifer B McCormick
Penn State College of Medicine
Co-authored papers 3
Matthew J Ferber
Mayo Clinic
Co-authored papers 3
Jamie K Bruflat
Mayo Clinic
Co-authored papers 3
Steven E Scherer
Baylor College of Medicine
Co-authored papers 3
Iftikhar J Kullo
Mayo Clinic
Co-authored papers 3
Richard R Sharp
Biomedical Ethics, Mayo Clinic and Foundation
Co-authored papers 3
Viktoriya Korchina
Co-authored papers 2
Euijung Ryu
Mayo Clinic
Co-authored papers 2
Harshavardhan Doddapaneni
Baylor College of Medicine
Co-authored papers 2
Cloann Schultz
Center for Individualized Medicine
Co-authored papers 2
Release 1.2